Brief: Interpace Biosciences Reports Q2 2020 Results
20/10/2020 14:38
Oct 20 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES ANNOUNCES SECOND QUARTER 2020
FINANCIAL
AND BUSINESS RESULTS
* Q2 REVENUE $5.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$5.9
MILLION
Source text for Eikon: ID:nGNX7Jjd1Z
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million